{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T03:22:38Z","timestamp":1784258558330,"version":"3.55.0"},"reference-count":51,"publisher":"American Society for Microbiology","issue":"10","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2010,10]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            The combination of liposomal amphotericin B (LAMB) and caspofungin (CAS) holds promise to improve the outcome of opportunistic invasive mycoses with poor prognosis. Little is known, however, about the safety and pharmacokinetics of the combination in patients at high risk for these infections. The safety and pharmacokinetics of the combination of LAMB and CAS were investigated in a risk-stratified, randomized, multicenter phase II clinical trial in 55 adult allogeneic hematopoietic stem cell recipients (aHSCT) with granulocytopenia and refractory fever. The patients received either CAS (50 mg\/day; day 1, 70 mg), LAMB (3 mg\/kg of body weight\/day), or the combination of both (CASLAMB) until defervescence and granulocyte recovery. Safety, development of invasive fungal infections, and survival were assessed through day 14 after the end of therapy. Pharmacokinetic sampling and analysis were performed on days 1 and 4. All three regimens were well tolerated. Premature study drug discontinuations due to grade III\/IV adverse events occurred in 1\/18, 2\/20, and 0\/17 patients randomized to CAS, LAMB, and CASLAMB, respectively. Adverse events not leading to study drug discontinuation were frequent but similar across cohorts, except for a higher frequency of hypokalemia with CASLAMB (\n            <jats:italic>P<\/jats:italic>\n            &lt; 0.05). Drug exposures were similar for patients receiving combination therapy and those randomized to monotherapy. There was no apparent difference in the occurrence of proven\/probable invasive fungal infections and survival through day 14 after the end of therapy. CASLAMB combination therapy in immunocompromised aHSCT patients was as safe as monotherapy with CAS or LAMB and had similar plasma pharmacokinetics, lending support to further investigations of the combination in the management of patients with invasive opportunistic mycoses.\n          <\/jats:p>","DOI":"10.1128\/aac.00425-10","type":"journal-article","created":{"date-parts":[[2010,7,27]],"date-time":"2010-07-27T00:51:41Z","timestamp":1280191901000},"page":"4143-4149","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":38,"title":["Randomized Comparison of Safety and Pharmacokinetics of Caspofungin, Liposomal Amphotericin B, and the Combination of Both in Allogeneic Hematopoietic Stem Cell Recipients"],"prefix":"10.1128","volume":"54","author":[{"given":"Andreas H.","family":"Groll","sequence":"first","affiliation":[{"name":"Infectious Disease Research Program, Center for Bone Marrow Transplantation and Department of Pediatric Hematology\/Oncology, University Children's Hospital Muenster, Muenster"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerda","family":"Silling","sequence":"additional","affiliation":[{"name":"Center for Bone Marrow Transplantation and Department of Internal Medicine, University Hospital Muenster, Muenster"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Young","sequence":"additional","affiliation":[{"name":"Centre for Clinical Trials (KKS), University Hospital Muenster, Muenster"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Schwerdtfeger","sequence":"additional","affiliation":[{"name":"Center for Blood Stem Cell and Bone Marrow Transplantation, Deutsche Klinik fu\u0308r Diagnostik Wiesbaden, Wiesbaden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmut","family":"Ostermann","sequence":"additional","affiliation":[{"name":"Center for Bone Marrow Transplantation, Department of Internal Medicine II, University Hospital Grosshadern, Munich"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner J.","family":"Heinz","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine II, University Hospital Wuerzburg, Wuerzburg"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Gerss","sequence":"additional","affiliation":[{"name":"Department of Medical Informatics and Biomathematics, University Hospital Muenster, Muenster"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hedwig","family":"Kolve","sequence":"additional","affiliation":[{"name":"Pharmacy Department, University Hospital Muenster, Muenster"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Lanvers-Kaminsky","sequence":"additional","affiliation":[{"name":"Experimental Pharmacology Section, Department of Pediatric Hematology\/Oncology, University Children's Hospital Muenster, Muenster"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joa\u0303o Paulo","family":"Vieira Pinheiro","sequence":"additional","affiliation":[{"name":"School of Public Health, University of Bielefeld, Bielefeld"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibylle","family":"Gammelin","sequence":"additional","affiliation":[{"name":"Centre for Clinical Trials (KKS), University Hospital Muenster, Muenster"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver A.","family":"Cornely","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Clinical Trials Centre Cologne, ZKS Ko\u0308ln, BMBF 01KN0706, and Centre for Integrated Oncology, CIO Ko\u0308ln-Bonn, University of Cologne, Cologne, Federal Republic of Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gudrun","family":"Wuerthwein","sequence":"additional","affiliation":[{"name":"Centre for Clinical Trials (KKS), University Hospital Muenster, Muenster"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11115"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1086\/323335"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.6.2546-2549.2005"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00880-06"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.41.11.2326"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.3.828-833.2002"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.50.2.632-638.2006"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11046-009-9196-6"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23109"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.12.4867-4875.2005"},{"key":"e_1_3_2_12_2","first-page":"1042","volume":"48","year":"2009","unstructured":"Cordonnier, C., C. Pautas, S. Maury, A. Vekhoff, H. Farhat, F. Suarez, N. Dh\u00e9din, F. Isnard, L. Ades, F. Kuhnowski, F. Foulet, M. Kuentz, P. Maison, S. Bretagne, and M. Schwarzinger. 2009. Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial. Clin. Infect. Dis. 200948:1042-1051.","journal-title":"Clin. Infect. Dis. 2009"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1086\/514341"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa061094"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(89)90441-5"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2009.03.003"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.10.8.1545"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkl009"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1054-3589(08)60129-5"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkg230"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01458-07"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11479"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60605-9"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1592\/phco.21.2.149.34109"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22348"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1086\/423381"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1086\/496927"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3062.2004.00065.x"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021585"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0507.2007.01377.x"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.12.4895-4902.2005"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2008.01983.x"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1086\/520980"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(82)90594-0"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1086\/589857"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1704516"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1086\/510677"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.8.3317-3324.2005"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2005.10.015"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1086\/599105"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.3.739-745.2002"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1704859"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.50.2.658-666.2006"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199903113401004"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.42.9.2391"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa040446"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.11.4536-4545.2005"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1002\/jps.20801"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1086\/375418"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11046-009-9193-9"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12281-008-0007-1"},{"key":"e_1_3_2_52_2","unstructured":"A1-591\u2032 Abstr. 49th Intersci. Conf. Antimicrob. Agents Chemother. 2009"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00425-10","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00425-10","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T20:16:11Z","timestamp":1645474571000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.00425-10"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":51,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["10.1128\/AAC.00425-10"],"URL":"https:\/\/doi.org\/10.1128\/aac.00425-10","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10]]},"assertion":[{"value":"2010-03-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2010-07-18","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2010-10-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}